ID26955A - HOMOGEN PHARMACEUTICAL COMPOSITION CONSIST OF ABACAVIR, LAMIVUDIN AND ZIDOVUDIN - Google Patents
HOMOGEN PHARMACEUTICAL COMPOSITION CONSIST OF ABACAVIR, LAMIVUDIN AND ZIDOVUDINInfo
- Publication number
- ID26955A ID26955A IDW20002479A ID20002479A ID26955A ID 26955 A ID26955 A ID 26955A ID W20002479 A IDW20002479 A ID W20002479A ID 20002479 A ID20002479 A ID 20002479A ID 26955 A ID26955 A ID 26955A
- Authority
- ID
- Indonesia
- Prior art keywords
- lamivudin
- zidovudin
- homogen
- abacavir
- pharmaceutical composition
- Prior art date
Links
- MCGSCOLBFJQGHM-SCZZXKLOSA-N abacavir Chemical compound C=12N=CN([C@H]3C=C[C@@H](CO)C3)C2=NC(N)=NC=1NC1CC1 MCGSCOLBFJQGHM-SCZZXKLOSA-N 0.000 title 1
- 229960004748 abacavir Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9809213.3A GB9809213D0 (en) | 1998-04-29 | 1998-04-29 | Pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID26955A true ID26955A (en) | 2001-02-22 |
Family
ID=10831228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20002479A ID26955A (en) | 1998-04-29 | 1999-04-26 | HOMOGEN PHARMACEUTICAL COMPOSITION CONSIST OF ABACAVIR, LAMIVUDIN AND ZIDOVUDIN |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1083932A1 (en) |
| JP (1) | JP2002512979A (en) |
| KR (1) | KR20010043128A (en) |
| CN (1) | CN1411380A (en) |
| AP (1) | AP2000001971A0 (en) |
| AU (1) | AU4135599A (en) |
| BR (1) | BR9910071A (en) |
| CA (1) | CA2330391A1 (en) |
| EA (1) | EA200000997A1 (en) |
| EE (1) | EE200000646A (en) |
| GB (1) | GB9809213D0 (en) |
| HR (1) | HRP20000732A2 (en) |
| HU (1) | HUP0101622A3 (en) |
| ID (1) | ID26955A (en) |
| IL (1) | IL139181A0 (en) |
| IS (1) | IS5675A (en) |
| NO (1) | NO20005418L (en) |
| NZ (1) | NZ507745A (en) |
| PL (1) | PL343710A1 (en) |
| SK (1) | SK16212000A3 (en) |
| TR (1) | TR200003157T2 (en) |
| WO (1) | WO1999055372A1 (en) |
| ZA (1) | ZA200005922B (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6875773B1 (en) | 1998-05-29 | 2005-04-05 | Ben M. Dunn | Combination therapy for treatment of FIV infection |
| EP1146882A2 (en) * | 1998-05-29 | 2001-10-24 | The University Of Florida | Combination of zidovudine (azt) with nucleoside analogs for treatment of feline immunodeficiency virus |
| GB9820417D0 (en) * | 1998-09-18 | 1998-11-11 | Glaxo Group Ltd | Antiviral combinations |
| US7074417B2 (en) * | 2000-10-13 | 2006-07-11 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-viral product, use and formulation thereof |
| HUP0500217A2 (en) * | 2002-04-23 | 2005-06-28 | Lupin Limited | Long-lasting matrix preparations with modified active ingredient release |
| TW200403061A (en) * | 2002-06-04 | 2004-03-01 | Glaxo Group Ltd | Pharmaceutical compositions |
| CN100335125C (en) * | 2003-06-03 | 2007-09-05 | 上海现代药物制剂工程研究中心 | Interferon nasal spray powder with long service for detoxication and anti-bacteria |
| WO2006114709A1 (en) * | 2005-04-25 | 2006-11-02 | Aurobindo Pharma Limited | Pharmaceutical compositions of antiretrovirals |
| WO2007013047A2 (en) * | 2005-07-29 | 2007-02-01 | Ranbaxy Laboratories Limited | Water-dispersible anti-retroviral pharmaceutical compositions |
| ES2279707B1 (en) * | 2005-11-10 | 2008-06-01 | Combino Pharm, S.L. | ORAL FORMULATIONS THAT INCLUDE 3'-AZIDONUCLEOSIDS. |
| BRPI0816498A2 (en) * | 2007-10-02 | 2019-02-26 | Emory University | potent combinations of zidovudine and drugs that select for k65r mutation in hiv polymerase |
| WO2009092002A1 (en) * | 2008-01-17 | 2009-07-23 | Duquesne University Of The Holy Spirit | Antiretroviral drug formulations for treatment of children exposed to hiv/aids |
| PE20160180A1 (en) | 2010-01-27 | 2016-05-04 | Viiv Healthcare Co | COMBINATIONS OF COMPOUNDS THAT INCLUDE INHIBITORS OF THE INTEGRASE OF HIV AND OTHER THERAPEUTIC AGENTS. |
| US20130115237A1 (en) | 2010-06-09 | 2013-05-09 | Vaccine Technologies, Incorporated | Therapeutic immunization in hiv infected subjects to augment antiretroviral treatment |
| EP2822560A1 (en) | 2012-03-05 | 2015-01-14 | Cipla Limited | Pharmaceutical antiretroviral combinations comprising lamivudine, festinavir and nevirapine |
| KR20150084772A (en) | 2012-10-23 | 2015-07-22 | 시플라 리미티드 | Pharmaceutical antiretroviral composition |
| PT3007695T (en) * | 2013-06-13 | 2024-03-07 | Akebia Therapeutics Inc | Compositions and methods for treating anemia |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY115461A (en) * | 1995-03-30 | 2003-06-30 | Wellcome Found | Synergistic combinations of zidovudine, 1592u89 and 3tc |
| GB9622681D0 (en) * | 1996-10-31 | 1997-01-08 | Glaxo Group Ltd | Pharmaceutical compositions |
-
1998
- 1998-04-29 GB GBGB9809213.3A patent/GB9809213D0/en not_active Ceased
-
1999
- 1999-04-26 WO PCT/EP1999/002794 patent/WO1999055372A1/en not_active Ceased
- 1999-04-26 HU HU0101622A patent/HUP0101622A3/en unknown
- 1999-04-26 CA CA002330391A patent/CA2330391A1/en not_active Abandoned
- 1999-04-26 HR HR20000732A patent/HRP20000732A2/en not_active Application Discontinuation
- 1999-04-26 TR TR2000/03157T patent/TR200003157T2/en unknown
- 1999-04-26 KR KR1020007012021A patent/KR20010043128A/en not_active Withdrawn
- 1999-04-26 AP APAP/P/2000/001971A patent/AP2000001971A0/en unknown
- 1999-04-26 EA EA200000997A patent/EA200000997A1/en unknown
- 1999-04-26 NZ NZ507745A patent/NZ507745A/en unknown
- 1999-04-26 IL IL13918199A patent/IL139181A0/en unknown
- 1999-04-26 EP EP99924822A patent/EP1083932A1/en not_active Withdrawn
- 1999-04-26 ID IDW20002479A patent/ID26955A/en unknown
- 1999-04-26 SK SK1621-2000A patent/SK16212000A3/en unknown
- 1999-04-26 CN CN99807983A patent/CN1411380A/en active Pending
- 1999-04-26 AU AU41355/99A patent/AU4135599A/en not_active Abandoned
- 1999-04-26 EE EEP200000646A patent/EE200000646A/en unknown
- 1999-04-26 JP JP2000545569A patent/JP2002512979A/en active Pending
- 1999-04-26 BR BR9910071-1A patent/BR9910071A/en not_active IP Right Cessation
- 1999-04-26 PL PL99343710A patent/PL343710A1/en unknown
-
2000
- 2000-10-20 IS IS5675A patent/IS5675A/en unknown
- 2000-10-23 ZA ZA200005922A patent/ZA200005922B/en unknown
- 2000-10-27 NO NO20005418A patent/NO20005418L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1411380A (en) | 2003-04-16 |
| HRP20000732A2 (en) | 2001-02-28 |
| EE200000646A (en) | 2002-04-15 |
| HUP0101622A2 (en) | 2002-03-28 |
| JP2002512979A (en) | 2002-05-08 |
| CA2330391A1 (en) | 1999-11-04 |
| AU4135599A (en) | 1999-11-16 |
| KR20010043128A (en) | 2001-05-25 |
| BR9910071A (en) | 2000-12-26 |
| AP2000001971A0 (en) | 2000-12-31 |
| PL343710A1 (en) | 2001-08-27 |
| EA200000997A1 (en) | 2001-06-25 |
| WO1999055372A1 (en) | 1999-11-04 |
| SK16212000A3 (en) | 2001-07-10 |
| HUP0101622A3 (en) | 2003-09-29 |
| IL139181A0 (en) | 2001-11-25 |
| NZ507745A (en) | 2004-07-30 |
| GB9809213D0 (en) | 1998-07-01 |
| IS5675A (en) | 2000-10-20 |
| NO20005418D0 (en) | 2000-10-27 |
| EP1083932A1 (en) | 2001-03-21 |
| ZA200005922B (en) | 2001-10-23 |
| TR200003157T2 (en) | 2001-01-22 |
| NO20005418L (en) | 2000-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID23673A (en) | PHARMACEUTICAL FORMULATION CONSIST OF AMOXICILIN AND KLAVULANAT | |
| ID26955A (en) | HOMOGEN PHARMACEUTICAL COMPOSITION CONSIST OF ABACAVIR, LAMIVUDIN AND ZIDOVUDIN | |
| ID29994A (en) | PHARMACEUTICAL COMPOSITION FOR AGAINST CCR5 CONSIST OF ANILIDA DECREASES | |
| ID22973A (en) | PHARMACEUTICAL COMPOSITION OF ORAL PROVISION FROM N-PIPERIDINO-3-PIRAZOLKARBOKSAMIDA, SALT AND ITS SOLVATES | |
| ID27922A (en) | PHARMACICAL COMPOSITION AND USE OF ANDROST-5-ENA-3β, 17β-DIOL | |
| IS5665A (en) | Pharmaceutical pressure spray composition | |
| PT1066027E (en) | PHARMACEUTICAL COMPOSITION OF TOPIRAMATO | |
| EE200300145A (en) | Aza and polyazanaphthalenylcarboxamides and pharmaceutical composition | |
| ID29437A (en) | COMBINATIONS OF FORMOTEROL AND FLUTIKASON PROPIONATE FOR ASMA | |
| ID21683A (en) | SOLID PHARMACEUTICAL COMPOSITION CONSIST OF CYCLOSPORINE AND ANIONIC SURFACE MATERIALS | |
| ID28270A (en) | COMPOSITION AND FORMULATION OF PEPTIDES AND USES | |
| PT998272E (en) | PHARMACEUTICAL COMPOSITION FOR COMBINATION OF PIPERIDINOALCANOL DECONGESTIONANT | |
| ID18663A (en) | COMPOSITION OF PHARMACEUTICAL PLATED PHARMACEUTICALS | |
| ID28709A (en) | COMBINATIONS OF TWO OR MORE ACTIVE MATERIALS USING MICROCAPSULATION FORMULATIONS | |
| EE200000468A (en) | The compounds, their use and the pharmaceutical composition | |
| ID29026A (en) | PHARMACEUTICAL COMPOSITION CONSIST OF ENTACAPONE OR NITECAPONE AND CROSS-CONNECTED CELLULOSE | |
| HUP9902655A3 (en) | Pharmaceutical composition of hedgehog proteins and use thereof | |
| SI0864559T1 (en) | Substituted amino compounds and their use as analgesic active substances | |
| ID26137A (en) | NEW PHARMACEUTICAL COMPOSITION OF TRIFOSPHATE URIDIN | |
| ID25535A (en) | THE COMPOSITION OF THE BODY CONTAINS FROM THE SOFTWARE DRUGS THAT ARE TRAPPED OUT OF ITS DISTANCE | |
| EE04681B1 (en) | 3,6-Half-Ketals of the 9a-Azalides, Method of Preparation and Pharmaceutical Composition | |
| ATE273697T1 (en) | PHARMACEUTICAL PREPARATION OF LEVOTHYROXINE | |
| PL361518A1 (en) | Application of the substance and pharmaceutical composition | |
| ID26040A (en) | CATALYTIC COMPOSITION CONSIST OF TITANIUM COMPOUND, AMINA PHOSFOR COMPOUND; MANUFACTURE AND USE OF IT | |
| EE9900034A (en) | Arylcycloalkanecarboxylic esters, their use, pharmaceutical compositions and their preparation |